Medscape Medical News: February 26, 2021. An FDA advisory panel lent their support today to a rapid clearance for Janssen/Johnson & Johnson’s COVID-19 vaccine, but several researchers expressed concerns to the panel about the lower standards of EUAs, including NCHR’s president Dr. Diana Zuckerman.
Read More »Tag: coronavirus vaccine
Will Covid-19 vaccines save lives? Current trials aren’t designed to tell us
October 21, 2020, BMJ. Current Covid-19 vaccine trials don’t give the public enough information on whether the vaccine is safe or will work for everyone.
Read More »HEALTH CARE BRIEFING: FDA Vaccine Rules Challenged as Weak
Bloomberg Gov, October 23, 2020. Scientists and advocates challenge coronavirus vaccine testing standards at FDA advisory meeting.
Read More »FDA Promises Strong Safety Standards for Covid-19 Vaccines as It Convenes Advisory Panel
WSJ, October 23, 2020. FDA promises strong safety testing for coronavirus vaccines even as current standards criticized at advisory meeting.
Read More »FDA Vaccine Rules Challenged as Weak at Advisory Panel Meeting
Bloomberg Business, October 23, 2020. We, with other, scientists and advocates criticize weak Covid-19 vaccine standards at FDA Advisory Panel Meeting.
Read More »